Recall archive
27 recalls · page 2 of 2
Reported May 22, 2019
Losartan Potassium Tab. USP 50mg, a) 30 count bottle (NDC 68788-0048-03) and b) 90 count bottle (NDC 68788-0048-09), Rx…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product details — CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable…
FDA (openFDA drug enforcement)
Reported Mar 27, 2019
Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottle (NDC: 68788-0048-03), b) 90-count bottle (NDC:…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product details — CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified.
FDA (openFDA drug enforcement)
Reported Aug 29, 2018
Valsartan Tablets USP 320 mg, 90-count, plastic child resistant bottle, Rx Only, Preferred Pharmaceuticals, Inc., 1250…
Moderate riskThis product could cause temporary or reversible health problems — stop using it.Preferred Pharmaceuticals, Inc.
Matched: Brand · Product · Product details — CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
FDA (openFDA drug enforcement)
RecallNow is not a government agency. Every notice above is published by the FDA, USDA FSIS, or CPSC and links back to its source. Back to the look-up